Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of haematology 2020-11, Vol.105 (5), p.667-671
Hauptverfasser:	Djebbari, Faouzi, Kaji, Furqaan, Stanton, Louise, Lawrence, Megan M., Collins, Graham P., Eyre, Toby A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Chemotherapy Humans immunology and infectious diseases Infections - etiology low‐grade lymphoma Lymphoma Lymphoma, Follicular - complications Lymphoma, Follicular - therapy Monoclonal antibodies Morbidity rituximab Targeted cancer therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!